Study to Evaluate the Efficacy and Safety of PF-07055480 in Moderately Severe to Severe Hemophilia A Adults

Condition:   Hemophilia A Intervention:   Biological: Recombinant AAV2/6 Human Factor VIII Gene Therapy Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials